Oncologix is
a manufacturer of medical devices also providing healthcare services in North
America. The Company, through its subsidiaries, operates and manufactures
medical device products and delivers Personal Healthcare Services.
Oncologix
has been moving in a series
of crests and through since 13th of March, 2015.OCLG touched its
high at $0.011 on February 19 at a trading volume of around $7.74 million in February,
2014.
The share price saw it’s highest of $0.01 while its
lowest was $0.00 in 52-week range. The stock maintains normal liquidity with
average volume of 2 million shares per day.
Oncologix is
in process to acquire a leading medical company and both the parties agreed to
close the deal with good faith and enter into a definitive stock purchase
agreement. The prospective of acquisition is to accelerate company’s growth in
terms of sales and expanding distribution network across U.S. and to increase
in growth of revenue.
Oncologix is currently
trading at a market valuation of around $1.19M. I would not trade this stock
here; I see much more downside potential than upside. OCLG is a typical
development stage company with total assets of $3.59 million having
$0.08million of cash& Equivalents. The company has total liabilities of
$4.62 million resulting in negative equity. OCLG trading in red yet continues
to trade in healthy volume, however does not seem to be moving anywhere close
to its earlier position in the near future.
Considering
the fundamentals its market capitalization of $1.19 million is clearly
overstated.

complete package
ReplyDelete